T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Broadcom
AVGO
|
+$3.01B |
| 2 |
Gilead Sciences
GILD
|
+$1.25B |
| 3 |
Accenture
ACN
|
+$1.09B |
| 4 |
XYZ
Block, Inc.
XYZ
|
+$1.06B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.84B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.47B |
| 4 |
Eli Lilly
LLY
|
+$1.43B |
| 5 |
Tesla
TSLA
|
+$1.4B |
Sector Composition
| 1 | Technology | 30.49% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.27% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Fortune Brands Innovations
FBIN
$6.98B
| $8.81M | ﹤0.01% |
144,700
+6,783
| +5% | +$413K |
|
1127
Moog
MOG.A
$6.32B
| $8.79M | ﹤0.01% |
50,726
+78
| +0.2% | +$13.5K |
|
1128
Teradata
TDC
$2.03B
| $8.79M | ﹤0.01% |
391,053
+330,179
| +542% | +$7.42M |
|
1129
Hyatt Hotels
H
$13.5B
| $8.79M | ﹤0.01% |
71,728
-923
| -1% | -$113K |
|
1130
Cars.com
CARS
$830M
| $8.77M | ﹤0.01% |
777,808
+17,318
| +2% | +$195K |
|
1131
Franklin Resources
BEN
$12.6B
| $8.64M | ﹤0.01% |
448,669
+16,049
| +4% | +$309K |
|
1132
SAP
SAP
$293B
| $8.61M | ﹤0.01% |
32,050
-9,443
| -23% | -$2.54M |
|
1133
NovoCure
NVCR
$1.43B
| $8.59M | ﹤0.01% |
482,034
-1,201,784
| -71% | -$21.4M |
|
1134
Mohawk Industries
MHK
$8.45B
| $8.5M | ﹤0.01% |
74,444
+111
| +0.1% | +$12.7K |
|
1135
American Financial Group
AFG
$11.5B
| $8.48M | ﹤0.01% |
64,532
-39,696
| -38% | -$5.21M |
|
1136
Korn Ferry
KFY
$3.8B
| $8.46M | ﹤0.01% |
124,635
+20,635
| +20% | +$1.4M |
|
1137
Royalty Pharma
RPRX
$15.2B
| $8.39M | ﹤0.01% |
269,463
+23,016
| +9% | +$717K |
|
|
PYCR
1138
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $8.33M | ﹤0.01% |
371,265
-6,372
| -2% | -$143K |
|
1139
Autoliv
ALV
$9.58B
| $8.21M | ﹤0.01% |
92,856
-37,823
| -29% | -$3.35M |
|
|
MBX
1140
MBX Biosciences, Inc. Common Stock
MBX
$337M
| $8.13M | ﹤0.01% |
1,100,916
-60,611
| -5% | -$447K |
|
1141
Freshworks
FRSH
$3.64B
| $8.06M | ﹤0.01% |
570,779
-441,869
| -44% | -$6.24M |
|
1142
Zillow
Z
$21.4B
| $8.01M | ﹤0.01% |
116,789
+9,580
| +9% | +$657K |
|
1143
Iovance Biotherapeutics
IOVA
$854M
| $8.01M | ﹤0.01% |
2,404,080
-224,021
| -9% | -$746K |
|
1144
Avantor
AVTR
$8.63B
| $7.98M | ﹤0.01% |
492,295
+28,984
| +6% | +$470K |
|
1145
Timken Company
TKR
$5.4B
| $7.92M | ﹤0.01% |
110,164
+17,213
| +19% | +$1.24M |
|
|
LENZ
1146
LENZ Therapeutics
LENZ
$1.16B
| $7.89M | ﹤0.01% |
306,978
-515,979
| -63% | -$13.3M |
|
1147
Hancock Whitney
HWC
$5.29B
| $7.86M | ﹤0.01% |
149,745
+85,824
| +134% | +$4.5M |
|
1148
Portland General Electric
POR
$4.62B
| $7.81M | ﹤0.01% |
175,124
+23,480
| +15% | +$1.05M |
|
1149
Antero Resources
AR
$10B
| $7.81M | ﹤0.01% |
193,062
+15,574
| +9% | +$630K |
|
|
BBNX
1150
Beta Bionics, Inc. Common Stock
BBNX
$1.05B
| $7.79M | ﹤0.01% |
+636,204
| New | +$7.79M |
|